Eshbal Functional Food Inc. (ESBL) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Eshbal Functional Food Inc. C$0.11, price C$0.09, upside +25.1%, quality 58 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Eshbal Functional Food Inc. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range C$0.0750 – C$0.3000 · fair‑value band C$0.0808 – C$0.1318 · the C$0.0850 price screens below the C$0.1063 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Eshbal Functional Food in your weekly email
Every Wednesday you see whether Eshbal Functional Food is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Eshbal Functional Food Inc. research, develops, and manufactures food products and dietary supplements Israel, North America, and Europe.
Show more
Eshbal Functional Food Inc. research, develops, and manufactures food products and dietary supplements Israel, North America, and Europe. The company manufactures gluten free baked products; and sugar-free products, vegan products, super-foods, dietary supplements, syrups, and dry mixes, including sweeteners and a line of low-carb products under the Eshbal du BARILI free living, Cargil, Confectioner, KOMIDA, and ZEN brand name. It offers its products through supermarkets, as well as other food retailers, health stores, and foodservice. The company was formerly known as Hakken Capital Corp. and changed its name to Eshbal Functional Food Inc. The company was founded in 1940 and is based in Vancouver, Canada.
Stock analysis
Eshbal Functional Food Inc. (ESBL) currently trades at C$0.0850, while our model-based Fair Value estimate is C$0.1063, implying the stock looks roughly 20.0% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of C$0.1000 per share, and 13 of the 22 models we run sit above the C$0.0850 price.
Bear case: the Asset-Based group reads lowest at C$0.0200, and 9 of the 22 models stay below the price. Evidence for this calculation is low.
Scenario range: C$0.0808 (bear) to C$0.1318 (bull), the price of C$0.0850 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 58/100 (solid quality), in the Consumer Defensive sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Eshbal Functional Food Inc. reported revenue of $11.4M in FY2024 versus $12.1M in FY2022, a compound −2.9%/yr. Reported net income was $313K in FY2024.
Key figures
Market cap C$11.6M (≈ $8.2M) · P/E ratio 8.5 · P/S ratio 0.23 · EPS (TTM) C$0.0100 · Net margin 2.7% · Return on equity −91.6% · Return on assets (EBIT) 3.9% · Operating margin 4.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
The share trades about 63% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at −2% fair-value upside, at 25%, ESBL screens cheaper than that median.
Fair Value models
Bear C$0.0808Fair Value C$0.1063Bull C$0.1318
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2024 figures (about 12 months old). Earnings retained since then (C$0.0100 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.50/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
not computed
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−1.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (figures in USD, USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −3.7% a year for the price.
Compare Eshbal Functional Food Inc. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 667 stocks
Beats the industry median on 6/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score58 · Above median
Fair Value upside+25% · Above median
Profitability
Return on assets−2% · Bottom 25%
Net margin (TTM)−21% · Bottom 25%
Operating margin (TTM)5% · Below median
Growth and dividend
Revenue growth43% · Top 25%
Balance sheet
Debt / equity0.07× · Below median
Valuation Multiplesvs Packaged Foods median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Eshbal Functional Food Inc. Fair Value". https://www.fairvalue-calculator.com/stock/ESBL
Frequently asked questions
Is Eshbal Functional Food Inc. (ESBL) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of C$0.1063 versus a price of C$0.0850, about +25% upside (undervalued).
What is the fair value of ESBL?
Our model-based fair value for Eshbal Functional Food Inc. is C$0.1063 (as of Sep 24, 2026), built from audited fundamentals. The current price: C$0.0850.
What is the quality score of ESBL?
Eshbal Functional Food Inc. has a Quality Score of 58/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Eshbal Functional Food Inc. (ESBL)?
Our model-based price target is the fair value of C$0.1063 (as of Sep 24, 2026) from 22 valuation models. Cautious scenario C$0.0808, optimistic scenario C$0.1318. It is a calculation from audited fundamentals, not an analyst target.
What is the Eshbal Functional Food Inc. stock forecast for 2026?
Our models put fair value at C$0.1063, about +25% upside versus a price of C$0.0850 (undervalued). Cautious scenario C$0.0808, optimistic scenario C$0.1318. The calculation is refreshed regularly with new filings.
What is the revenue of Eshbal Functional Food Inc. (ESBL)?
Eshbal Functional Food Inc. reported trailing-twelve-month revenue of about $15.4M (latest available figure, as of Sep 24, 2026).
What growth is priced into Eshbal Functional Food Inc. (ESBL)?
For today's price to be fair in a discounted-cash-flow model, Eshbal Functional Food Inc. would have to grow free cash flow by -1.5 % per year for five years (discount rate 8.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 2 years revenue grew -3.0 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of ESBL use?
Our models discount Eshbal Functional Food Inc. at 8.3 %: a base by market capitalisation (nano), damped by beta 0.11, country premium for Canada. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Eshbal Functional Food Inc. that is -1.5 % per year a year over ten years, using the same discount rate (8.3 %) and the same formula as our fair value.
How much growth has Eshbal Functional Food Inc. (ESBL) delivered so far?
Over the past 2 years revenue at Eshbal Functional Food Inc. grew -3.0 % a year. The price currently implies -1.5 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Eshbal Functional Food Inc. (ESBL) growing?
The median revenue growth in the sector is +2.7 % a year. That is the yardstick for the growth priced into Eshbal Functional Food Inc. (-1.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Eshbal Functional Food Inc. (ESBL)?
The free-cash-flow yield on the price is 12.13 %: that much free cash flow Eshbal Functional Food Inc. produces per unit of market value. When it exceeds the discount rate of our models (8.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Eshbal Functional Food Inc. (ESBL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Eshbal Functional Food Inc. it is C$0.1063 per share (as of Sep 24, 2026), against a price of C$0.0850. It is the blended result of 22 valuation models (cash flow, earnings, asset, dividend).
Is Eshbal Functional Food Inc. stock overvalued or undervalued in 2026?
As of Sep 24, 2026, ESBL trades below its calculated fair value: price C$0.0850, fair value C$0.1063, a gap of about +25% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ESBL?
No. The price is what the market pays today (C$0.0850); the fair value is what the company's own numbers justify (C$0.1063). For Eshbal Functional Food Inc. the two are C$0.0213 per share apart. That gap is exactly why we show both numbers side by side.
How much is Eshbal Functional Food Inc. worth?
The market values Eshbal Functional Food Inc. at about C$11.6M (market capitalisation, as of Sep 24, 2026). Per share that is C$0.0850; our models calculate a fair value of C$0.1063 per share.
What do the bullish and bearish scenarios say about ESBL?
Our models span a range for Eshbal Functional Food Inc.: cautious scenario C$0.0808, base C$0.1063, optimistic C$0.1318 per share (as of Sep 24, 2026, price C$0.0850). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ESBL?
Eshbal Functional Food Inc. trades at a price-to-earnings ratio of 8.5 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of C$0.1063 is built from several models across several years. Other multiples: P/B 3.2, P/S 0.5.
How solid is the balance sheet of Eshbal Functional Food Inc. (ESBL)?
Balance-sheet figures for Eshbal Functional Food Inc. (as of Sep 24, 2026): return on equity −91.6%, debt of 0.07 per unit of equity. They feed the Quality Score of 58/100, which measures business quality independently of the share price.
How far is ESBL from its 52-week high?
Eshbal Functional Food Inc. trades at C$0.0850, about 63% below its 52-week high of C$0.2300 and at the low of C$0.0850 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of C$0.1063 is for.
Which stocks are comparable to Eshbal Functional Food Inc.?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, The Kraft Heinz Company, Foshan Haitian Flavouring and Food Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Eshbal Functional Food Inc. stock attractive at the current price?
The data as of Sep 24, 2026: price C$0.0850, calculated fair value C$0.1063 (+25%), Quality Score 58/100, from 22 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ESBL calculated?
We run Eshbal Functional Food Inc. through 22 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of C$0.1063, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Eshbal Functional Food Inc. currently trades 25 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Eshbal Functional Food Inc. (ESBL)?
The closing price on Sep 23, 2026 was C$0.0850. Our model-based fair value is C$0.1063, about +25% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Eshbal Functional Food Inc. right now?
Solid quality (58/100) at a price below fair value, the discount is the argument here, not the business quality. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Eshbal Functional Food Inc.
How large is the market capitalisation of Eshbal Functional Food Inc. (ESBL)?
The market capitalisation of Eshbal Functional Food Inc. is C$11.6M (≈ $8.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Eshbal Functional Food Inc. (ESBL)?
The price-to-sales ratio of Eshbal Functional Food Inc. is 0.23 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Eshbal Functional Food Inc. (ESBL)?
Earnings per share at Eshbal Functional Food Inc. are C$0.0100 (price ÷ EPS = P/E 8.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Eshbal Functional Food Inc. (ESBL)?
The net margin of Eshbal Functional Food Inc. is 2.7% (fiscal year 2024). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Eshbal Functional Food Inc. (ESBL)?
The return on equity (ROE) of Eshbal Functional Food Inc. is −91.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Eshbal Functional Food Inc. (ESBL)?
On an EBIT basis the return on assets of Eshbal Functional Food Inc. is 3.9% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Eshbal Functional Food Inc. (ESBL)?
The operating margin of Eshbal Functional Food Inc. is 4.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Eshbal Functional Food Inc. (ESBL)?
Revenue at Eshbal Functional Food Inc. is growing +43.4% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Eshbal Functional Food Inc. (ESBL)?
Earnings per share at Eshbal Functional Food Inc. are growing −97.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Eshbal Functional Food Inc. (ESBL) carry?
The net debt of Eshbal Functional Food Inc. is $2.5M (fiscal year 2024, ≈ 5.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Eshbal Functional Food Inc. in the live analysis
One click puts Eshbal Functional Food Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
